Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27772 | 0.80 | HTT (0.50) | CES2CES1TDP1HTTCYP3A4 | |
| SCHEMBL29431520 | 0.80 | HTT (0.50) | CES2CES1TDP1HTTCYP3A4 | |
| SCHEMBL205832 | 0.80 | HTT (0.45) | CES2CES1TDP1HTTCYP3A4 | |
| Hydrochloric Acid SCHEMBL10715453 | 0.77 | HTT (0.48) | CES2CES1TDP1HTTCYP3A4 | |
| SCHEMBL6903601 | 0.77 | HTT (0.48) | CES2CES1TDP1HTTCYP3A4 | |
| SCHEMBL3630379 | 0.77 | HTT (0.48) | CES2CES1TDP1HTTCYP3A4 | |
| SCHEMBL11158141 | 0.77 | HTT (0.48) | CES2CES1TDP1HTTCYP3A4 | |
| SCHEMBL5693960 | 0.77 | HTT (0.48) | CES2CES1TDP1HTTCYP3A4 | |
| SCHEMBL6227879 | 0.77 | HTT (0.43) | CES2CES1TDP1HTTCYP3A4 | |
| SCHEMBL5406015 | 0.77 | HTT (0.43) | CES2CES1TDP1HTTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112142746-B | Benzodiazepine compound, preparation method and medical application thereof | 四川大学华西医院 | 2021-09-24 | — | — | CN | disclosed |
| CN-112142746-A | Benzodiazepine compound, preparation method and medical application thereof | 四川大学华西医院 | 2020-12-29 | — | — | CN | disclosed |
| EP-0741123-B1 | Process for the preparation of salts of substituted or unsubstituted phthalic acid derivatives | CLARIANT GMBH (DE) | 2002-09-18 | — | — | EP | disclosed |
| US-5723658-A | Process for the preparation of salts of substituted or unsubstituted phthalic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-03-03 | — | — | US | disclosed |
| EP-0741123-A1 | Process for the preparation of salts of substituted or unsubstituted phthalic acid derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-11-06 | — | — | EP | disclosed |
| EP-0578165-B1 | Process for the preparation of tetrafluorophthalic acid and/or tetrafluorophthalic anhydride | HOECHST AG (DE) | 1996-06-05 | — | — | EP | disclosed |
| US-5384413-A | Reacting an N-(N'-benzylideneamino)tetrafluorophthalimide with water, removing the water azeotropically and solvent extracting | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-01-24 | — | — | US | disclosed |
| EP-0578165-A1 | Process for the preparation of tetrafluorophthalic acid and/or tetrafluorophthalic anhydride | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-01-12 | — | — | EP | disclosed |